Abstract:Openness and sharing of discovery lie at the heart of the scientific method. Yet historically, the data and reports upon which they are based have not been easily accessible and often require onerous efforts to obtain. From this was borne the open data movement, which has advanced research and transformed public health policy-making in countries that have embraced this change. Open health data refers to unrestricted, free-of-charge access to health data [1]. By making health data available to all without any limitations to its reuse, it leverages national transparency, accountability, participation, innovation, and research through a multitude of data sources in large volumes—as well as paving the way for the creation of novel citizen-centric services [1,2]. The ability to access and combine diverse health data enriches analytical capacity and evaluation that can inform national policy development and improve healthcare delivery [3,4]. Open health data is therefore a public resource and should be delivered purposefully and proactively, in line with user needs and its potential contribution to value creation [2]. However, the open data movement comes with the need to balance its benefits with the security and privacy challenges that come with it, such as the risk of re-identification [4]. The issue of selling medical data to commercial organizations such as pharmaceutical companies, insurance companies, and other private companies has also stirred much controversy and raised concerns about ethicality, reproducibility, and generalizability [5]. Undeniably, challenges to the implementation of open health data remain, including the lack of awareness of its potential benefits, unsteady leadership and accountability, and weak legal and ethical oversight. Additionally, addressing the enormous gap in resources and knowledge on tools and techniques is acutely needed to make the technological shift to open and interoperable databases with unified protocols, frameworks, and terminology [3]. Despite the challenges in open health data, numerous countries and institutions have proven its feasibility with the proper legislation and implementation. By incorporating formal requirements in national open data strategies, laws, and regulations, the majority of Organisation for Economic Cooperation and Development (OECD) member countries have successfully adopted and scaled up "open by default" and "government as platform" approaches to data [2]. This has resulted in stronger governance frameworks and an increase in data availability, paving the way for the publication and use of open government data in various sectors geared towards social, government, and business innovation, with potentially important implications for public sector integrity, sustainable development, and gender equality [2]. With the passage of its e-government law, Germany has catapulted its data accessibility in recent years to provide data in machine-readable formats, with metadata descriptions, free of charge, and with unrestricted access for reuse [2]. Upon adoption of its Open Data Charter, Canada also released a number of online databases, such as The Public Health InfoBase and PulseNet Canada, which offer easy-to-use tools for accessing public health data on chronic diseases, mental health conditions, and foodborne molecular surveillance, to name a few [3]. Additionally, the widely utilized, freely-accessible critical care MIMIC databases have provided scientific opportunities for academic and industrial research, quality improvement initiatives, and higher education coursework [6–8]. Conversely, there is a critical need for the United Nations and other global organizations like the World Health Organization (WHO) to develop and espouse open health data as a global strategy as this movement consequently cascades to the regional and national levels.

Public consultation for European health data space is open

The European Health Data Space: Too Big To Succeed?

European Health Data Space—An Opportunity Now to Grasp the Future of Data-Driven Healthcare

Ethical and social reflections on the proposed European Health Data Space

Are EU member states ready for the European Health Data Space? Lessons learnt on the secondary use of health data from the TEHDAS Joint Action

Real World Evidence: methodological issues and opportunities from the European Health Data Space

Bridging the European Data Sharing Divide in Genomic Science

Collaboration in Healthcare: Implications of Data Sharing for Secondary Use in the European Union

Expanding citizen engagement in the secondary use of health data: an opportunity for national health data access bodies to realise the intentions of the European health data space

Exploring the accessibility of primary health care data in Europe's COVID-19 response: developing key indicators for managing future pandemics (Eurodata study)

A critique of the regulation of data science in healthcare research in the European Union

Position paper on management of personal data in environment and health research in Europe

Patients' knowledge, preferences, and perspectives about data protection and data control: an exploratory survey

Access to regulatory data from the European Medicines Agency: the times they are a-changing

A Future European Scientific Dialogue Regulatory Framework: Connecting the Dots

European health regulations reduce registry-based research

Assessing Cross-Border Telemedicine Data Exchange in the European Union: A Call to Action

Cooperating on Data: The Missing Element in Bringing Real Innovation to Europe's Healthcare Systems

Call to action for global and national actors for open health data

Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences?

What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate